Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Parallel-Group, Assessment of the Efficacy, Safety and Tolerability of CX157 (TriRima) 60mg Three Times a Day (TID) in Subjects With Major Depressive Disorder

NCT00739908 is registered in ClinicalTrials.gov with CeNeRx BioPharma Inc. as lead sponsor.

NCT NCT00739908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00739908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Parallel-Group, Assessment of the Efficacy, Safety and Tolerability of CX157 (TriRima) 60mg Three Times a Day (TID) in Subjects With Major Depressive Disorder
Lead sponsor
CeNeRx BioPharma Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2008
Completion date
July 31, 2009
Enrollment
285 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder